Unknown

Dataset Information

0

NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system.

ABSTRACT: BACKGROUND:Myriad infectious and noninfectious causes of encephalomyelitis (EM) have similar clinical manifestations, presenting serious challenges to diagnosis and treatment. Metabolomics of cerebrospinal fluid (CSF) was explored as a method of differentiating among neurological diseases causing EM using a single CSF sample. METHODOLOGY/PRINCIPAL FINDINGS:1H NMR metabolomics was applied to CSF samples from 27 patients with a laboratory-confirmed disease, including Lyme disease or West Nile Virus meningoencephalitis, multiple sclerosis, rabies, or Histoplasma meningitis, and 25 controls. Cluster analyses distinguished samples by infection status and moderately by pathogen, with shared and differentiating metabolite patterns observed among diseases. CART analysis predicted infection status with 100% sensitivity and 93% specificity. CONCLUSIONS/SIGNIFICANCE:These preliminary results suggest the potential utility of CSF metabolomics as a rapid screening test to enhance diagnostic accuracies and improve patient outcomes.

SUBMITTER: French CD 

PROVIDER: S-EPMC6312347 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

<h4>Background</h4>Myriad infectious and noninfectious causes of encephalomyelitis (EM) have similar clinical manifestations, presenting serious challenges to diagnosis and treatment. Metabolomics of cerebrospinal fluid (CSF) was explored as a method of differentiating among neurological diseases causing EM using a single CSF sample.<h4>Methodology/principal findings</h4>1H NMR metabolomics was applied to CSF samples from 27 patients with a laboratory-confirmed disease, including Lyme disease or  ...[more]

Similar Datasets

Unknown Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement.
| S-EPMC9953577 | biostudies-literature
Unknown Direction and magnitude of cerebrospinal fluid flow vary substantially across central nervous system diseases.
| S-EPMC8017867 | biostudies-literature
Unknown Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas.
| S-EPMC6895823 | biostudies-literature
Unknown Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.
| S-EPMC3291832 | biostudies-literature
Unknown A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors.
| S-EPMC8466839 | biostudies-literature
Unknown Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.
| S-EPMC10439243 | biostudies-literature
Unknown Vascular endothelial growth factor concentrations in the cerebrospinal fluid of dogs with neoplastic or inflammatory central nervous system disorders.
| S-EPMC8295675 | biostudies-literature
Unknown Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid.
| S-EPMC4981784 | biostudies-literature
Unknown Blood and cerebrospinal fluid characteristics in neonates with a suspected central nervous system infection.
| S-EPMC6636939 | biostudies-literature
Unknown Central Nervous System Metabolism in Autism, Epilepsy and Developmental Delays: A Cerebrospinal Fluid Analysis.
| S-EPMC9148155 | biostudies-literature